BSE Live
Jan 23, 16:01Prev. Close
201.30
Open Price
203.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:53Prev. Close
207.16
Open Price
204.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
207.16 (2141)
| Key Financial Ratios of Viyash Scientific (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.63 | 0.03 | -0.24 | 0.60 | 1.30 | |
| Diluted EPS (Rs.) | 0.62 | 0.03 | -0.24 | 0.59 | 1.30 | |
| Cash EPS (Rs.) | 0.98 | 0.38 | 0.12 | 0.98 | 1.66 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 45.65 | 43.59 | 42.43 | 41.55 | 41.45 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 45.65 | 43.59 | 42.43 | 41.55 | 41.45 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.50 | |
| Revenue from Operations/Share (Rs.) | 7.12 | 6.76 | 8.93 | 8.84 | 10.69 | |
| PBDIT/Share (Rs.) | 1.58 | 0.77 | 0.08 | 1.08 | 2.22 | |
| PBIT/Share (Rs.) | 1.23 | 0.42 | -0.29 | 0.70 | 1.86 | |
| PBT/Share (Rs.) | 0.88 | -0.01 | -0.39 | 0.63 | 1.65 | |
| Net Profit/Share (Rs.) | 0.63 | 0.02 | -0.24 | 0.60 | 1.29 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 22.18 | 11.46 | 0.84 | 12.24 | 20.81 | |
| PBIT Margin (%) | 17.32 | 6.15 | -3.24 | 7.87 | 17.37 | |
| PBT Margin (%) | 12.36 | -0.14 | -4.37 | 7.14 | 15.40 | |
| Net Profit Margin (%) | 8.86 | 0.36 | -2.73 | 6.73 | 12.09 | |
| Return on Networth / Equity (%) | 1.38 | 0.05 | -0.57 | 1.43 | 3.11 | |
| Return on Capital Employed (%) | 2.69 | 0.95 | -0.68 | 1.65 | 4.47 | |
| Return on Assets (%) | 1.29 | 0.05 | -0.54 | 1.31 | 2.91 | |
| Total Debt/Equity (X) | 0.04 | 0.04 | 0.02 | 0.02 | 0.01 | |
| Asset Turnover Ratio (%) | 0.15 | 0.15 | 0.20 | 0.20 | 24.08 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.42 | 1.07 | 1.38 | 1.81 | 1.69 | |
| Quick Ratio (X) | 1.09 | 0.72 | 0.60 | 0.97 | 1.04 | |
| Inventory Turnover Ratio (X) | 5.98 | 2.49 | 1.97 | 2.18 | 5.80 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 3,317.90 | 2,921.43 | 1,829.57 | 3,325.80 | 5,987.71 | |
| EV/Net Operating Revenue (X) | 18.61 | 17.34 | 8.22 | 15.14 | 22.56 | |
| EV/EBITDA (X) | 83.88 | 151.24 | 972.14 | 123.67 | 108.36 | |
| MarketCap/Net Operating Revenue (X) | 18.37 | 17.07 | 8.13 | 15.13 | 22.54 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 2.87 | 2.65 | 1.71 | 3.22 | 5.81 | |
| Price/Net Operating Revenue | 18.37 | 17.07 | 8.13 | 15.13 | 22.54 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
02.12.2025
Sequent Scienti Standalone September 2025 Net Sales at Rs 34.03 crore, down 18.96% Y-o-Y
22.08.2025
Sequent Scienti Standalone June 2025 Net Sales at Rs 41.07 crore, down 28.78% Y-o-Y
21.05.2025
Sequent Scienti Standalone March 2025 Net Sales at Rs 42.33 crore, up 15.12% Y-o-Y
24.02.2025
Sequent Scienti Consolidated December 2024 Net Sales at Rs 390.81 crore, up 18.66% Y-o-Y